Retirement Planning Co of New England, Inc. - INHIBIKASE THERAPEUTICS INC ownership

INHIBIKASE THERAPEUTICS INC's ticker is IKT and the CUSIP is 45719W106. A total of 27 filers reported holding INHIBIKASE THERAPEUTICS INC in Q4 2021. The put-call ratio across all filers is - and the average weighting 0.1%.

Quarter-by-quarter ownership
Retirement Planning Co of New England, Inc. ownership history of INHIBIKASE THERAPEUTICS INC
ValueSharesWeighting
Q1 2023$22,950
+30.4%
34,900
-0.9%
0.01%
+27.3%
Q4 2022$17,606
-66.8%
35,212
-40.4%
0.01%
-71.1%
Q3 2022$53,000
+12.8%
59,069
-8.6%
0.04%
+18.8%
Q2 2022$47,000
-72.7%
64,606
-44.5%
0.03%
-67.0%
Q1 2022$172,000
-20.4%
116,402
-21.0%
0.10%
-7.6%
Q4 2021$216,000147,3310.10%
Other shareholders
INHIBIKASE THERAPEUTICS INC shareholders Q4 2021
NameSharesValueWeighting ↓
ACT CAPITAL MANAGEMENT, LLC 937,500$853,0001.18%
HAMILTON LANE ADVISORS LLC 165,635$151,0000.06%
Redmond Asset Management, LLC 122,477$111,0000.04%
Retirement Planning Co of New England, Inc. 59,069$53,0000.04%
CCG WEALTH MANAGEMENT, LLC 20,000$18,0000.01%
Koshinski Asset Management, Inc. 65,377$59,0000.01%
ZEKE CAPITAL ADVISORS, LLC 93,800$85,0000.01%
K.J. Harrison & Partners Inc 18,300$17,0000.01%
Warberg Asset Management LLC 14,493$13,0000.00%
BLAIR WILLIAM & CO/IL 179,000$163,0000.00%
View complete list of INHIBIKASE THERAPEUTICS INC shareholders